Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03071393 · ClinicalTrials.gov registry record · NA
Intermittent Hypoxia to Enhance Motor Function After Spinal Cord Injury
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT03071393 is a NA study that has completed, run by University of Florida. The registered enrollment target is 17 participants.
The verdict
NCT03071393, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This study will examine if acute intermittent hypoxia (brief episodes of breathing lower oxygen), which has been shown to enhance plasticity and motor output, can enhance functional outcomes and muscle activation in individuals with spinal cord injury. Our aim is to assess breathing, sitting, standing and walking functional ability before and after acute intermittent hypoxia, compared to a sham treatment. This information may be useful in advancing rehabilitation for people with spinal cord injuries.
Interventions
- DEVICE Hypoxia via Hypoxico Hyp-123
- DEVICE Sham via Hypoxico Hyp-123
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2017-07-10 |
| Est. Completion | 2020-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03071393
The ClinicalTrials.gov registry entry for NCT03071393 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Hypoxia via Hypoxico Hyp-123 is the first listed.
NCT03071393 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03071393 about?
NCT03071393 is a clinical study titled "Intermittent Hypoxia to Enhance Motor Function After Spinal Cord Injury". This study will examine if acute intermittent hypoxia (brief episodes of breathing lower oxygen), which has been shown to enhance plasticity and motor output, can enhance functional outcomes and muscle activation in individuals with spinal cord injury. Our aim is to assess breathing, sitting, standi...
What is the current status of trial NCT03071393?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2017-07-10. Estimated completion is 2020-09-01.
What interventions are being tested in trial NCT03071393?
The interventions under investigation include: Hypoxia via Hypoxico Hyp-123 (DEVICE), Sham via Hypoxico Hyp-123 (DEVICE).
Who is sponsoring clinical trial NCT03071393?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.